In 2016, MED completed 3 reports on hemophilia.
- Weight-based Dosing Strategies for Factor Replacement Therapy in Hemophilia A and B
- Use of Ultrasound to Diagnose Hemarthrosis and Monitor Joint Health in Hemophilia
- Home Care Services and Utilization Management for Appropriate Use of Factor Replacement Therapy in Patients with Hemophilia
These reports summarize the evidence on the comparative effectiveness and costs of factor replacement dosing strategies based on ideal body weight (IDW), rather than actual body weight (ABW); summarize the current evidence on effectiveness and costs of using ultrasound in the management of hemophilia A and B; and summarize the evidence for the effectiveness and cost effectiveness of different home-care services for patients with hemophilia. MED member states approved the public release of these 3 reports.